black box warning for glp 1 agonists The popularity of GLP-1 weight loss drugs is bringing back a historic affliction…scurvy. DETAILS: https://fox8.com/news/glp-1 -drugs-may-cause-scurvy-in-patients-reports The obesity drug semaglutide (Wegovy)
Description
It reminds us we are alive
The advent of oral formulations, including semaglutide and ofrutide, has further enhanced patient adherence
Liraglutide (Victoza) injection [package insert]
doi: 10.1186/s12933-022-01686-3 93 LiJJiCZhangWLanLGeW
GLP-1 receptor agonists have been shown to reduce sodium reabsorption and promote diuresis through actions in the renal proximal tubule
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: A randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
